Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants

Review (4 trials, n=138) found insufficient evidence to determine if CGM improves preterm infant mortality or morbidities. Long‐term outcomes were not reported. None of trials reported the neurodevelopmental outcome, i.e. the primary outcome of this review

Cochrane Database of Systematic Reviews